An in silico predictive model for TdP based on multiple ion channel inhibition
Publication date: September–October 2019Source: Journal of Pharmacological and Toxicological Methods, Volume 99Author(s): Todd Wisialowski, Stephen Jenkinson, Mark Gosink (Source: Journal of Pharmacological and Toxicological Methods)
Source: Journal of Pharmacological and Toxicological Methods - November 1, 2019 Category: Drugs & Pharmacology Source Type: research

Challenge for the in silico translation of Na channel blockade effects on human-ECG parameters
Publication date: September–October 2019Source: Journal of Pharmacological and Toxicological Methods, Volume 99Author(s): Takashi Yoshinaga, Taeko Kubo, Keiichi Asakura, Yasuyuki Abe, Ryuuta Saitou, Takafumi Shirakawa, Yoshiyuki Furukawa, Takashi Ashihara (Source: Journal of Pharmacological and Toxicological Methods)
Source: Journal of Pharmacological and Toxicological Methods - November 1, 2019 Category: Drugs & Pharmacology Source Type: research

Comparison of telemetry-derived activity generated from rodent cardiovascular studies with quantitative open field locomotor activity
Publication date: September–October 2019Source: Journal of Pharmacological and Toxicological Methods, Volume 99Author(s): Vincent Bernardo, Cheryl Tyszkiewicz, Siddhartha Bhatt, Todd Wisialowski, Susan Goody (Source: Journal of Pharmacological and Toxicological Methods)
Source: Journal of Pharmacological and Toxicological Methods - November 1, 2019 Category: Drugs & Pharmacology Source Type: research

Use of PK/PD modelling of nonclinical cardiovascular data to aid in ex vivo-to-in vivo and cross-species translation
Publication date: September–October 2019Source: Journal of Pharmacological and Toxicological Methods, Volume 99Author(s): William Gorczyca, Todd Wisialowski, Jennifer Colangelo (Source: Journal of Pharmacological and Toxicological Methods)
Source: Journal of Pharmacological and Toxicological Methods - November 1, 2019 Category: Drugs & Pharmacology Source Type: research

Prediction of drug-effects on cardiac repolarization in humans: What can we learn from the past to refine our drug discovery strategies?
Publication date: September–October 2019Source: Journal of Pharmacological and Toxicological Methods, Volume 99Author(s): Jean-Pierre Valentin, Jean-Michel Guillon, Peter K. Hoffman, Catherine Ortemann-Renon, John Koerner, Jennifer Pierson, Gary A. Gintant, James Willard, Matthew Skinner, Todd Wisialowski, Michael Pugsley (Source: Journal of Pharmacological and Toxicological Methods)
Source: Journal of Pharmacological and Toxicological Methods - November 1, 2019 Category: Drugs & Pharmacology Source Type: research

Hypothermia-induced QTc prolongation in non-human primates; Why you should measure body temperature in cardiovascular safety studies
Publication date: September–October 2019Source: Journal of Pharmacological and Toxicological Methods, Volume 99Author(s): Todd Wisialowski, Jason Cordes, Betty Pettersen, Declan Flynn (Source: Journal of Pharmacological and Toxicological Methods)
Source: Journal of Pharmacological and Toxicological Methods - November 1, 2019 Category: Drugs & Pharmacology Source Type: research

Evaluation of cardiovascular risk related to a monoclonal antibody mediated increase in vascular endothelial growth factor in conscious normal rats
Publication date: September–October 2019Source: Journal of Pharmacological and Toxicological Methods, Volume 99Author(s): Kathy Derakhchan, Ruth Reeves, Dennis Keefe, Suezanne Parker, Galen Carey (Source: Journal of Pharmacological and Toxicological Methods)
Source: Journal of Pharmacological and Toxicological Methods - November 1, 2019 Category: Drugs & Pharmacology Source Type: research

Concordance of Ion Channel, Cardiomyocyte, and Preclinical Species in Proarrhythmia Cardiac Safety Evaluation
Publication date: September–October 2019Source: Journal of Pharmacological and Toxicological Methods, Volume 99Author(s): Emily P. Kaushik (Source: Journal of Pharmacological and Toxicological Methods)
Source: Journal of Pharmacological and Toxicological Methods - November 1, 2019 Category: Drugs & Pharmacology Source Type: research

Moving from detection of cardiovascular liabilities to quantitative mechanistic understanding: Concepts, challenges and opportunities
Publication date: September–October 2019Source: Journal of Pharmacological and Toxicological Methods, Volume 99Author(s): Amy Pointon, Michael G. Rolf (Source: Journal of Pharmacological and Toxicological Methods)
Source: Journal of Pharmacological and Toxicological Methods - November 1, 2019 Category: Drugs & Pharmacology Source Type: research

Integrating efficacy and safety: Telemetry and echocardiography in a pig model of myocardial infarction
Publication date: September–October 2019Source: Journal of Pharmacological and Toxicological Methods, Volume 99Author(s): Michael G. Rolf, Stuart Purbrick, Madeleine Antonsson, Frank Seeliger, Martin Billger (Source: Journal of Pharmacological and Toxicological Methods)
Source: Journal of Pharmacological and Toxicological Methods - November 1, 2019 Category: Drugs & Pharmacology Source Type: research

Development and characterization of a nerve conduction model in anesthetized non-human primates as a tool to assess compound-dependent peripheral nervous system risk
Publication date: September–October 2019Source: Journal of Pharmacological and Toxicological Methods, Volume 99Author(s): Theodore Detwiler, Christopher Regan, Hillary Regan, Gary Sitko, Frederick Sannajust (Source: Journal of Pharmacological and Toxicological Methods)
Source: Journal of Pharmacological and Toxicological Methods - November 1, 2019 Category: Drugs & Pharmacology Source Type: research

Getting more from blood pressure signals: Use of pulse wave analysis (PWA) to enable greater insight to compound-dependent hemodynamic effects
Publication date: September–October 2019Source: Journal of Pharmacological and Toxicological Methods, Volume 99Author(s): Christopher Regan, Hillary Regan, Patrick Fanelli, Frederick Sannajust (Source: Journal of Pharmacological and Toxicological Methods)
Source: Journal of Pharmacological and Toxicological Methods - November 1, 2019 Category: Drugs & Pharmacology Source Type: research

Measurement of heart rate variability (HRV) and spontaneous baroreflex sensitivity (sBRS) provides valuable information on compound-dependent cardiovascular effects to enhance safety risk assessment
Publication date: September–October 2019Source: Journal of Pharmacological and Toxicological Methods, Volume 99Author(s): Christopher Regan, Patrick Fanelli, Hillary Regan, Theodore Detwiler, Pierre Morissette, Shaun Gruver, Frederick Sannajust (Source: Journal of Pharmacological and Toxicological Methods)
Source: Journal of Pharmacological and Toxicological Methods - November 1, 2019 Category: Drugs & Pharmacology Source Type: research

Evaluation of clinically-relevant proarrhythmic ECG biomarkers in conscious beagle dogs using a newly developed multiple lead ECG telemetry implant
Publication date: September–October 2019Source: Journal of Pharmacological and Toxicological Methods, Volume 99Author(s): Christopher Regan, Tom Delahanty, Robert Brockway, Patrick Fanelli, Hillary Regan, Theodore Detwiler, Shaun Gruver, Gary Miller, Frederick Sannajust (Source: Journal of Pharmacological and Toxicological Methods)
Source: Journal of Pharmacological and Toxicological Methods - November 1, 2019 Category: Drugs & Pharmacology Source Type: research

Is the current non-clinical drug development safety paradigm effective for assessing cardiovascular liabilities?
Publication date: September–October 2019Source: Journal of Pharmacological and Toxicological Methods, Volume 99Author(s): Brian Roche, John Ross, Carlos A. Obejero-Paz, James Kramer (Source: Journal of Pharmacological and Toxicological Methods)
Source: Journal of Pharmacological and Toxicological Methods - November 1, 2019 Category: Drugs & Pharmacology Source Type: research